SGS doubles NJ lab capacity; Pfizer licenses OMT's technology;

> SGS has doubled the size of its labs in Fairfield, NJ, offering 30,000 square feet of laboratory space replete with new equipment for biopharmaceutical development. News

> After a similar deal with WuXi PharmaTech ($WX), Open Monoclonal Technology has licensed its rat models to Pfizer ($PFE) for antibody development. Article

> Quintiles has signed a deal with Comprehensive Clinical Development, giving Comprehensive first refusal to work on Quintiles' sponsored clinical trials. More

> JHP Pharmaceuticals says it has inked an agreement with an undisclosed drugmaker to manufacture a lyophilized biologic for late-stage clinical trials. Story

> AMRI has signed a discovery pact with Knopp Biosciences, agreeing to collaborate on central nervous system drugs. Item

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.